Phenylketonurias clinical trials
The registry lists 191 studies for Phenylketonurias across more than 10 countries. 40 are recruiting or about to start. 182 of them are mainly about Phenylketonurias (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-10.
Get an email when these change. Save the Phenylketonurias studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your saved searches, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your saved searches. Stop any time.
Who runs them
BioMarin Pharmaceutical (35) · Vitaflo International, Ltd (11) · Otsuka Pharmaceutical Development & Commercialization, Inc. (6) · Emory University (6) · Nutricia UK Ltd (6) · Boston Children's Hospital (5) · University Hospital, Tours (5) · University of Missouri-Columbia (5)
What is being tested here
Drugs under test in Phenylketonurias studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted
Coming up
Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.
The 10 nearest, phase 3 first
- Nov 2027A Long-Term Study of JNT-517 in Participants With Phenylketonuria · Phase 3 · Otsuka Pharmaceutical Development & Commercialization, Inc.
- Nov 2026A Trial to Examine the Interaction of Repinatrabit With Ethinyl Estradiol/Norethindrone, Metformin,Carbamazepine, Rosuvastatin, and Methotrexate When Administered Together · Otsuka Pharmaceutical Development & Commercialization, Inc.
- Nov 2026Early Check: Expanded Screening in Newborns · RTI International
- Dec 2026Impact Of A Phe-Restricted Diet On Gut Health In Children With PKU · Birmingham Women's and Children's NHS Foundation Trust
- Dec 2026Phenylalanine-free Diet for Patients With Secondary Hyperphenylalaninemia in ICU · Chang Gung Memorial Hospital
- Dec 2026GMP Powdered Substitutes in PKU and TYR · Nutricia UK Ltd
- Feb 2027A Trial to Examine if Repinatrabit is Processed Differently in Adults With Reduced Liver or Kidney Function Compared to Adults With Normal Liver and Kidney Function · Otsuka Pharmaceutical Development & Commercialization, Inc.
- Mar 2027Impact of Phenylalanine Elevations on Brain and Cognition in Adult PKU Carriers · University of Missouri-Columbia
- Mar 2027The Psychosocial Functioning of Adults With Phenylketonuria. · Central Hospital, Nancy, France
- Mar 2027PheCheck™ Validation Study · Aptatek BioSciences, Inc
Who these studies take
Of the 31 Phenylketonurias studies recruiting now, 14 (45%) set no upper age limit and 17 (55%) stop at 75 or younger. 15 (48%) take children under 18. 1 (3%) are for women only and 0 (0%) for men only; 8 (26%) take healthy volunteers.
| Age | Women | Men |
|---|---|---|
| 10 | 12 (39%) | 12 (39%) |
| 18 | 26 (84%) | 25 (81%) |
| 30 | 26 (84%) | 25 (81%) |
| 40 | 26 (84%) | 25 (81%) |
| 50 | 25 (81%) | 24 (77%) |
| 65 | 19 (61%) | 18 (58%) |
| 75 | 15 (48%) | 14 (45%) |
| 85 | 14 (45%) | 13 (42%) |
Across all 191 studies, recruiting or not: 56% stop at 75 or younger and 50% at 65; 61% take children; 3% are for women only and 2% for men only; 24% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.
How long Phenylketonurias studies take
Of 33 interventional studies with no phase under Phenylketonurias, half reached primary completion within 22 months of starting, counting those still running.
| Start to primary completion | Every sponsor | Industry | Non-industry |
|---|---|---|---|
| Interventional, no phase | 22 mo9–28 · 33 studies | — | — |
| Observational | 45 mo17–95 · 22 studies | — | — |
Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out
What changed recently
From the registry's own updates since Oct 14, 2026.
Newly registered1
- A First-in-Human Study of Phelimin in Healthy Volunteers and Adults With PKUNov 10, 2026NCT07927608
Studies
Recruiting first, then most recently updated. Showing 50 of 191. Browse all 191 → or search them.
- A First-in-Human Study of Phelimin in Healthy Volunteers and Adults With PKUNot yet recruitingNCT07927608Phase 11 country
- Immune Modulation During Palynziq® Treatment in Adults (IMPALA)RecruitingNCT07477691Phase 41 country
- A Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AG-181 in Subjects With PhenylketonuriaRecruitingNCT07241234Phase 12 countries
- A Study of Sepiapterin in Participants With Phenylketonuria (PKU)RecruitingNCT06302348Phase 37 countries
- A Study of MZE782 in Adults With PKURecruitingNCT07694440Phase 23 countries
- Impact of Phenylalanine Elevations on Brain and Cognition in Adult PKU CarriersRecruitingNCT07220265Not applicable1 country
- A Study of JNT-517 in Participants With Phenylketonuria (PKU)RecruitingNCT06971731Phase 310 countries
- Market Research of a Slow Release Protein Substitute for the Dietary Management of PKUNot yet recruitingNCT07802366Not applicable1 country
- Impact Of A Phe-Restricted Diet On Gut Health In Children With PKURecruitingNCT077280321 country
- PKU Microtablets Case StudiesNot yet recruitingNCT07671859Not applicable1 country
- The Impact of Frequency of Home Phenylalanine Measurements on Metabolic Control in a Population of Patients With Classic PhenylketonuriaRecruitingNCT07825883Not applicable1 country
- To Evaluate the Safety and Efficacy of GS1168 Injection in Adult PhenylketonuriaNot yet recruitingNCT07318909Early Phase 11 country
- PheCheck™ Validation StudyRecruitingNCT075519211 country
- AAV Gene Therapy Clinical Study in Adult Classic PKU (PHEdom)RecruitingNCT06332807Phase 1/21 country
- Safety and Efficacy Study of NGGT002 in Adult Patients With PhenylketonuriaRecruitingNCT06687733Phase 1/21 country
- A Trial to Examine if Repinatrabit is Processed Differently in Adults With Reduced Liver or Kidney Function Compared to Adults With Normal Liver and Kidney FunctionRecruitingNCT07713758Phase 11 country
- A Trial to Examine the Interaction of Repinatrabit With Ethinyl Estradiol/Norethindrone, Metformin,Carbamazepine, Rosuvastatin, and Methotrexate When Administered TogetherRecruitingNCT07446400Phase 11 country
- Prevalence and Determinants of Obesity in PKU PatientsEnrolling by invitationNCT077030201 country
- Eating Disorders in Patients With PhenylketonuriaRecruitingNCT076987431 country
- GenSci144 Tablets Phase I Clinical TrialRecruitingNCT07685210Phase 11 country
- A Clinical Study on the Safety and Tolerability of PL54 Injection in Adult Patients With Phenylketonuria (PKU)RecruitingNCT07672756Phase 11 country
- Announcement of Rare Metabolic Diseases in Systematic Newborn Screening: the Phenylketonuria Experience.RecruitingNCT062893481 country
- Educational, Social Support, and Nutritional Interventions and Their Cumulative Effect on Pregnancy Outcomes and Quality of Life in Teen and Adult Women With PhenylketonuriaRecruitingNCT01659749Not applicable1 country
- Multiomics Approach in Adult Patients With PhenylketonuriaRecruitingNCT074849451 country
- A Long-Term Study of JNT-517 in Participants With PhenylketonuriaRecruitingNCT06628128Phase 32 countries
- A Long-term, Post-marketing Safety Study of Palynziq in Patients With PKU (PALace)RecruitingNCT058136783 countries
- A Long Term, Post-marketing Study of Immune Response in Patients Receiving Palynziq Treatment for PKU (PALisade)RecruitingNCT063052341 country
- Phenylalanine-free Diet for Patients With Secondary Hyperphenylalaninemia in ICURecruitingNCT04896281Not applicable1 country
- The Psychosocial Functioning of Adults With Phenylketonuria.Not yet recruitingNCT07406009
- Nutritional Impacts of Palynziq on Patients With Phenylketonuria (PKU)RecruitingNCT044045301 country
- Development of Novel Psychological Assessment Tools and Anxiety Intervention for PhenylketonuriaRecruitingNCT06560736Not applicable1 country
- GMP Powdered Substitutes in PKU and TYRRecruitingNCT06941532Not applicable1 country
- Brain Aging in PhenylketonuriaRecruitingNCT069692091 country
- A Self-test Home-use Blood Phenylalanine Monitoring System Under the Brand Name Egoo Phe System Has Been Developed for Measurement of Phenylalanine (Phe) in Individuals Diagnosed With Phenylketonuria (PKU): The Study Purpose is to Evaluate Accuracy and UsabilityEnrolling by invitationNCT069401931 country
- Metabolic Control and Patient Well-being in Phenylketonuria: do Guidelines Make a Difference?RecruitingNCT051281491 country
- Effect of Large Neutral Amino Acids in Adults With Classical PhenylketonuriaRecruitingNCT06337864Not applicable1 country
- Walking Program in Fatty Liver Children With PhenylketonuriaRecruitingNCT06718842Not applicable1 country
- Evaluation of Capillary Blood Collection Devices (Mitra® and HemaPEN®)RecruitingNCT058941221 country
- Long-Term Follow Up Study of Subjects Previously Administered HMI 102Enrolling by invitationNCT043487081 country
- Comparison of Atherogenic Risk Factors and Efficacy of Nutritional Treatment Among Adult Phenylketonuria PatientsNot yet recruitingNCT04969809Not applicable
- Rapid Drug Desensitization Study in Adults Experiencing Hypersensitivity Reactions to PalynziqCompletedNCT06780332Phase 41 country
- Effect of Different Meal Types Given Before Exercise on Plasma Amino Acid Levels and Metabolic Control Parameters in Classical Phenylketonuria Patients Undergoing Aerobic and Resistance ExercisesCompletedNCT07526909Not applicable1 country
- A Long-Term Safety Study of PTC923 in Participants With PhenylketonuriaCompletedNCT05166161Phase 319 countries
- Safety and Efficacy Study of NGGT002 in PKU Adult SubjectsActive, not recruitingNCT06061614Early Phase 11 country
- Study to Evaluate the Safety and Efficacy of Pegvaliase in Adolescents (Ages 12-17) With PhenylketonuriaActive, not recruitingNCT05270837Phase 32 countries
- First-in-Human, Multiple Part Clinical Study of JNT-517 in Healthy Participants and in Participants With PhenylketonuriaCompletedNCT05781399Phase 1/22 countries
- Early Check: Expanded Screening in NewbornsActive, not recruitingNCT036552231 country
- Nutrition Status of Adults With PKU Before and During Treatment With PegvaliaseCompletedNCT038562031 country
- Study of a National Cohort of Adult Patients With PhenylketonuriaCompletedNCT016197221 country
- Life With Phenylketonuria. Adult Neurological Outcome of PCU Screened Patients From 1971 to 2002.TerminatedNCT044337281 country